Novamed Orthotics Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 24-10-2024
- Paid Up Capital ₹ 7.50 M
as on 24-10-2024
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.75 M
as on 24-10-2024
- Revenue 6.35%
(FY 2023)
- Profit 13.95%
(FY 2023)
- Ebitda 8.98%
(FY 2023)
- Net Worth 5.41%
(FY 2023)
- Total Assets 14.57%
(FY 2023)
About Novamed Orthotics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹3.75 M.
Chandra Rajendra, Nalla Rajesh, Gujar Nandini, and One other member serve as directors at the Company.
- CIN/LLPIN
U52520KA2019PTC124504
- Company No.
124504
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Novamed Orthotics Private Limited offer?
Novamed Orthotics Private Limited offers a wide range of products and services, including Orthopedic Equipment & Supplies, Upper Body Orthotic Devices, Physiotherapy & Rehab Aids, Fracture Aid, Traction Equipment, Lower Body Orthotic Device, Rehab Splints.
Who are the key members and board of directors at Novamed Orthotics?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandra Rajendra  | Director | 07-Aug-2020 | Current |
| Nalla Rajesh | Director | 07-Aug-2020 | Current |
| Gujar Nandini | Additional Director | 19-Sep-2022 | Current |
| Vinita | Additional Director | 01-Jul-2022 | Current |
Financial Performance of Novamed Orthotics.
Novamed Orthotics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.35% increase. The company also saw a substantial improvement in profitability, with a 13.95% increase in profit. The company's net worth moved up by a moderate rise of 5.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novamed Orthotics?
In 2023, Novamed Orthotics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Feb 2024 | ₹3.75 M | Open |
How Many Employees Work at Novamed Orthotics?
Unlock and access historical data on people associated with Novamed Orthotics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novamed Orthotics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novamed Orthotics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
